Geriatric nutritional risk index as an easy-to-use assessment tool for nutritional status in hepatocellular carcinoma treated with atezolizumab plus bevacizumab

被引:13
|
作者
Hiraoka, Atsushi [1 ]
Kumada, Takashi [2 ]
Tada, Toshifumi [3 ]
Hirooka, Masashi [4 ]
Kariyama, Kazuya [5 ]
Tani, Joji [6 ]
Atsukawa, Masanori [7 ]
Takaguchi, Koichi [8 ]
Itobayashi, Ei [9 ]
Fukunishi, Shinya [10 ]
Tsuji, Kunihiko [11 ]
Ishikawa, Toru [12 ]
Tajiri, Kazuto [13 ]
Ochi, Hironori [14 ]
Yasuda, Satoshi [15 ]
Toyoda, Hidenori [15 ]
Ogawa, Chikara [16 ]
Nishimura, Takashi [17 ]
Hatanaka, Takeshi [18 ]
Kakizaki, Satoru [19 ]
Shimada, Noritomo [20 ]
Kawata, Kazuhito [21 ]
Naganuma, Atsushi [22 ]
Kosaka, Hisashi [23 ]
Matono, Tomomitsu [24 ]
Kuroda, Hidekatsu [25 ]
Yata, Yutaka [26 ]
Ohama, Hideko [1 ]
Tada, Fujimasa [1 ]
Nouso, Kazuhiro [5 ]
Morishita, Asahiro [6 ]
Tsutsui, Akemi [8 ]
Nagano, Takuya [8 ]
Itokawa, Norio [7 ]
Okubo, Tomomi [7 ]
Arai, Taeang [7 ]
Imai, Michitaka [12 ]
Koizumi, Yohei [4 ]
Nakamura, Shinichiro [3 ]
Iijima, Hiroko [17 ]
Kaibori, Masaki [23 ]
Hiasa, Yoichi [4 ]
机构
[1] Ehime Prefectural Cent Hosp, Gastroenterol Ctr, Matsuyama, Ehime 7900024, Japan
[2] Gifu Kyoritsu Univ, Dept Nursing, Ogaki, Japan
[3] Japanese Red Cross Himeji Hosp, Dept Internal Med, Himeji, Hyogo, Japan
[4] Ehime Univ, Dept Gastroenterol & Metabol, Grad Sch Med, Toon, Japan
[5] Okayama City Hosp, Dept Hepatol, Okayama, Japan
[6] Kagawa Univ, Dept Gastroenterol & Hepatol, Takamatsu, Kagawa, Japan
[7] Nippon Med Sch, Div Gastroenterol & Hepatol, Dept Internal Med, Tokyo, Japan
[8] Kagawa Prefectural Cent Hosp, Dept Hepatol, Takamatsu, Kagawa, Japan
[9] Asahi Gen Hosp, Dept Gastroenterol, Asahi, Japan
[10] Osaka Med & Pharmaceut Univ, Dept Gastroenterol, Osaka, Japan
[11] Teine Keijinkai Hosp, Ctr Gastroenterol, Sapporo, Hokkaido, Japan
[12] Saiseikai Niigata Hosp, Dept Gastroenterol, Niigata, Japan
[13] Toyama Univ Hosp, Dept Gastroenterol, Toyama, Japan
[14] Japanese Red Cross Matsuyama Hosp, Hepatobiliary Ctr, Matsuyama, Ehime, Japan
[15] Ogaki Municipal Hosp, Dept Gastroenterol & Hepatol, Ogaki, Japan
[16] Japanese Red Cross Takamatsu Hosp, Dept Gastroenterol, Takamatsu, Kagawa, Japan
[17] Hyogo Coll Med, Dept Gastroenterol & Hepatol, Nishinomiya, Hyogo, Japan
[18] Gunma Saiseikai Maebashi Hosp, Dept Gastroenterol, Maebashi, Gunma, Japan
[19] Natl Hosp Org Takasaki Gen Med Ctr, Dept Clin Res, Takasaki, Gumma, Japan
[20] Otakanomori Hosp, Div Gastroenterol & Hepatol, Kashiwa, Chiba, Japan
[21] Hamamatsu Univ, Hepatol Div, Dept Internal Med II, Sch Med, Hamamatsu, Shizuoka, Japan
[22] Natl Hosp Org Takasaki Gen Med Ctr, Dept Gastroenterol, Takasaki, Gumma, Japan
[23] Kansai Med Univ, Dept Surg, Hirakata, Osaka, Japan
[24] St Marys Hosp, Dept Hepatol, Himeji, Hyogo, Japan
[25] Iwate Med Univ, Sch Med, Dept Internal Med, Div Hepatol, Morioka, Iwate, Japan
[26] Hanwa Mem Hosp, Dept Gastroenterol, Osaka, Japan
关键词
atezolizumab plus bevacizumab; geriatric nutritional risk index; modified albumin-bilirubin grade; nutrition; sarcopenia; MANAGEMENT; GUIDELINES; LENVATINIB; SORAFENIB;
D O I
10.1111/hepr.13934
中图分类号
R57 [消化系及腹部疾病];
学科分类号
摘要
AimThe present study focused on Geriatric Nutritional Risk Index (GNRI), which is based on bodyweight and serum albumin, and known as an easy-to-use nutritional assessment tool in clinical settings, to elucidate the prognostic predictive ability of GNRI in patients treated with atezolizumab plus bevacizumab (Atez/Bev) for hepatocellular carcinoma (HCC). MethodsA total of 525 HCC patients treated with Atez/Bev, based on their classification of unsuitable status for curative treatments and/or transarterial catheter chemoembolization, were enrolled (Child-Pugh A:B:C = 484:40:1, Barcelona Clinic Liver Cancer stage 0:A:B:C:D = 7:25:192:283:18). Prognosis was evaluated retrospectively using GNRI. ResultsAtez/Bev was used in 338 of the present cohort as first-line systemic chemotherapy (64.4%). Median progression-free survival based on GNRI indicating normal, mild decline, moderate decline, and severe decline was 8.3, 6.7, 5.3, and 2.4 months, respectively, whereas median overall survival was 21.4, 17.0, 11.5. and 7.3 months, respectively (both p < 0.001). The concordance index (c-index) values of GNRI for predicting prognosis (progression-free survival/overall survival) were superior to those of Child-Pugh class and albumin-bilirubin grade (0.574/0.632 vs. 0.527/0.570 vs. 0.565/0.629). As a subanalysis, muscle volume loss was observed in 37.5% of 256 patients with computed tomography data available. Along with GNRI decline, frequency of muscle volume loss became progressively larger (normal vs. mild vs. moderate vs. severe = 17.6% vs. 29.2% vs. 41.2% vs. 57.9%, p < 0.001), and a GNRI value of 97.8 was predictive of its occurrence (AUC 0.715, 95% CI 0.649-0.781; specificity/sensitivity = 0.644/0.688). ConclusionThese findings indicate that GNRI is an effective nutritional prognostic tool for predicting prognosis and muscle volume loss complication in HCC patients treated with Atez/Bev.
引用
收藏
页码:1031 / 1042
页数:12
相关论文
共 50 条
  • [21] The use of the Geriatric Nutritional Risk Index (GNRI) as a simplified nutritional screening tool - Reply to E Cereda and C Pedrolli
    Kumagai, Hiromichi
    Yamaguchi, Yuri
    Ohkawa, Sakae
    Yamada, Kohsuke
    Furuya, Ryuichi
    Takita, Takako
    AMERICAN JOURNAL OF CLINICAL NUTRITION, 2008, 87 (06): : 1967 - 1967
  • [22] Impact of body mass index in patients receiving atezolizumab plus bevacizumab for hepatocellular carcinoma
    Vithayathil, Mathew
    D'Alessio, Antonio
    Weinmann, Arndt
    Galle, Peter
    Fulgenzi, Claudia Angela Maria
    Fessas, Petros
    Bettinger, Dominik
    Bengsch, Bertram
    Vogel, Arndt
    Balcar, Lorenz
    Scheiner, Bernhard
    Muzaffar, Mahvish
    Amara, Suneetha
    Muhammed, Ambreen
    Naqash, Abdul Rafeh
    Personeni, Nicola
    Pressiani, Tiziana
    Cammarota, Antonella
    Pinter, Matthias
    Cortellini, Alessio
    Rimassa, Lorenza
    Pinato, David J.
    Sharma, Rohini
    JOURNAL OF HEPATOLOGY, 2022, 77 : S374 - S375
  • [23] Impact of body mass index in patients receiving atezolizumab plus bevacizumab for hepatocellular carcinoma
    Vithayathil, Mathew
    D'Alessio, Antonio
    Fulgenzi, Claudia Angela Maria
    Nishida, Naoshi
    Schoenlein, Martin
    von Felden, Johann
    Schulze, Kornelius
    Wege, Henning
    Saeed, Anwaar
    Wietharn, Brooke
    Hildebrand, Hannah
    Wu, Linda
    Ang, Celina
    Marron, Thomas U.
    Weinmann, Arndt
    Galle, Peter R.
    Bettinger, Dominik
    Bengsch, Bertram
    Vogel, Arndt
    Balcar, Lorenz
    Scheiner, Bernhard
    Lee, Pei-Chang
    Huang, Yi-Hsiang
    Amara, Suneetha
    Muzaffar, Mahvish
    Naqash, Abdul Rafeh
    Cammarota, Antonella
    Zanuso, Valentina
    Pressiani, Tiziana
    Pinter, Matthias
    Cortellini, Alessio
    Kudo, Masatoshi
    Rimassa, Lorenza
    Pinato, David J.
    Sharma, Rohini
    HEPATOLOGY INTERNATIONAL, 2023, 17 (04) : 904 - 914
  • [24] Hepatic Events and Viral Kinetics in Hepatocellular Carcinoma Patients Treated With Atezolizumab Plus Bevacizumab
    Hsu, Chiun
    Ducreux, Michel
    Zhu, Andrew X.
    Qin, Shukui
    Ikeda, Masafumi
    Kim, Tae-You
    Galle, Peter R.
    Finn, Richard S.
    Chen, Ethan
    Ma, Ning
    Hu, Youyou
    Li, Lindong
    Cheng, Ann-Lii
    LIVER CANCER, 2023, 12 (01) : 44 - 56
  • [25] Double cancer of primary hepatic angiosarcoma and hepatocellular carcinoma treated with atezolizumab plus bevacizumab
    Yamauchi, Yurika
    Saeki, Issei
    Yamasaki, Takahiro
    Egusa, Maho
    Nishiyama, Natsuko
    Fujioka, Tsuyoshi
    Kawamoto, Daiki
    Nishimura, Tatsuro
    Tanabe, Norikazu
    Oono, Takashi
    Matsumoto, Toshihiko
    Ishikawa, Tsuyoshi
    Marumoto, Yoshio
    Matsukuma, Satoshi
    Shindo, Yoshitaro
    Tokumitsu, Yukio
    Yoshimine, Sota
    Murakami, Junichi
    Tanaka, Toshiki
    Kimura, Sotai
    Hoshii, Yoshinobu
    Hamano, Kimikazu
    Nagano, Hiroaki
    Takami, Taro
    HEPATOLOGY RESEARCH, 2023, 53 (07) : 681 - 686
  • [26] Geriatric nutritional risk index and newly developed scoring system as prognosis prediction for unresectable hepatocellular carcinoma patients treated with lenvatinib
    Ohama, Hideko
    Hiraoka, Atsushi
    Tada, Toshifumi
    Hirooka, Masashi
    Kariyama, Kazuya
    Tani, Joji
    Atsukawa, Masanori
    Takaguchi, Koichi
    Itobayashi, Ei
    Fukunishi, Shinya
    Tsuji, Kunihiko
    Ishikawa, Toru
    Tajiri, Kazuto
    Ochi, Hironori
    Yasuda, Satoshi
    Toyoda, Hidenori
    Ogawa, Chikara
    Nishimura, Takashi
    Hatanaka, Takeshi
    Kakizaki, Satoru
    Shimada, Noritomo
    Kawata, Kazuhito
    Naganuma, Atsushi
    Kosaka, Hisashi
    Matono, Tomomitsu
    Kuroda, Hidekatsu
    Yata, Yutaka
    Tanaka, Hironori
    Nishikawa, Hiroki
    Shibata, Hiroshi
    Tada, Fujimasa
    Nouso, Kazuhiro
    Morishita, Asahiro
    Tsutsui, Akemi
    Nagano, Takuya
    Itokawa, Norio
    Okubo, Tomomi
    Arai, Taeang
    Imai, Michitaka
    Koizumi, Yohei
    Nakamura, Shinichiro
    Iijima, Hiroko
    Kaibori, Masaki
    Hiasa, Yoichi
    Kumada, Takashi
    SCIENTIFIC REPORTS, 2025, 15 (01):
  • [27] Geriatric Nutritional Risk Index as a Predictor of Prognosis in Metastatic Renal Cell Carcinoma Treated with Nivolumab
    Fujiwara, Ryo
    Yuasa, Takeshi
    Yamamoto, Shinya
    Fujiwara, Motohiro
    Takemura, Kosuke
    Urasaki, Tetsuya
    Oki, Ryosuke
    Komai, Yoshinobu
    Oguchi, Tomohiko
    Numao, Noboru
    Yonese, Junji
    NUTRITION AND CANCER-AN INTERNATIONAL JOURNAL, 2023, 75 (02): : 670 - 677
  • [28] Nutritional status and risk of all-cause mortality in patients undergoing transcatheter aortic valve replacement assessment using the geriatric nutritional risk index and the controlling nutritional status score
    Lee, Kyusup
    Ahn, Jung-Min
    Kang, Do-Yoon
    Ko, Euihong
    Kwon, Osung
    Lee, Pil Hyung
    Lee, Seung-Whan
    Kim, Dae-Hee
    Kim, Ho Jin
    Kim, Joon Bum
    Choo, Suk Jung
    Park, Duk-Woo
    Park, Seung-Jung
    CLINICAL RESEARCH IN CARDIOLOGY, 2020, 109 (02) : 161 - 171
  • [29] Nutritional status and risk of all-cause mortality in patients undergoing transcatheter aortic valve replacement assessment using the geriatric nutritional risk index and the controlling nutritional status score
    Kyusup Lee
    Jung-Min Ahn
    Do-Yoon Kang
    Euihong Ko
    Osung Kwon
    Pil Hyung Lee
    Seung-Whan Lee
    Dae-Hee Kim
    Ho Jin Kim
    Joon Bum Kim
    Suk Jung Choo
    Duk-Woo Park
    Seung-Jung Park
    Clinical Research in Cardiology, 2020, 109 : 161 - 171
  • [30] The ability of the Geriatric Nutritional Risk Index to assess the nutritional status and predict the outcome of home-care resident elderly: a comparison with the Mini Nutritional Assessment
    Cereda, Emanuele
    Pusani, Chiara
    Limonta, Daniela
    Vanotti, Alfredo
    BRITISH JOURNAL OF NUTRITION, 2009, 102 (04) : 563 - 570